Goutham Narla

Goutham Narla

Auto-generated profile, based on publicly available information

Goutham Narla

University of Michigan

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2001 in Science
Verified
Journal Article
Closed access
PDF file
GNGoutham Narla
Goutham Narla
KHKaren E. Heath
Karen E. Heath
HRHelen L. Reeves
Helen L. Reeves
DLDan Li
Dan Li
LGLuciana E. Giono
Luciana E. Giono
SFScott L. Friedman
Scott L. Friedman
Kruppel-like factor 6 ( KLF6 ) is a zinc finger transcription factor of unknown function. Here, we show that the KLF6 gene is mutated in a subset of human prostate cancer. Loss-of-heterozygosity analysis revealed that one KLF6 allele is deleted in 77% (17 of 22) of primary prostate tumors. Sequence analysis of the retained KLF6 allele revealed mutations in 71% of these tumors. Functional studies confirm that whereas wild-type KLF6 up-regulates p21 (WAF1/CIP1) in a p53-independent manner and significantly reduces cell proliferation, tumor-derived KLF6 mutants do not. Our data suggest that KLF6 is a tumor suppressor gene involved in human prostate cancer.

28 October 2015 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
JSJaya Sangodkar
Jaya Sangodkar
CFCaroline C. Farrington
Caroline C. Farrington
KMKimberly McClinch
Kimberly McClinch
MGMatthew D. Galsky
Matthew D. Galsky
DKDavid B. Kastrinsky
David B. Kastrinsky
GNGoutham Narla
Goutham Narla
Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase involved in the regulation of many cellular processes. A confirmed tumor suppressor protein, PP2A is genetically altered or functionally inactivated in many cancers highlighting a need for its therapeutic reactivation. In this review we discuss recent literature on PP2A: the elucidation of its structure and the functions of its subunits, and the identification of molecular lesions and post‐translational modifications leading to its dysregulation in cancer. A final section will discuss the proteins and small molecules that modulate PP2A and how these might be used to target dysregulated forms of PP2A to treat cancers and other diseases.

7 January 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
APAditya Parikh
Aditya Parikh
CLChristine Lee
Christine Lee
PJPeronne Joseph
Peronne Joseph
SMSergio Marchini
Sergio Marchini
ABAlessia Baccarini
Alessia Baccarini
ADAnalisa DiFeo
Analisa DiFeo
Ovarian cancer is a leading cause of cancer deaths among women. Effective targets to treat advanced epithelial ovarian cancer (EOC) and biomarkers to predict treatment response are still lacking because of the complexity of pathways involved in ovarian cancer progression. Here we show that miR-181a promotes TGF-β-mediated epithelial-to-mesenchymal transition via repression of its functional target, Smad7. miR-181a and phosphorylated Smad2 are enriched in recurrent compared with matched-primary ovarian tumours and their expression is associated with shorter time to recurrence and poor outcome in patients with EOC. Furthermore, ectopic expression of miR-181a results in increased cellular survival, migration, invasion, drug resistance and in vivo tumour burden and dissemination. In contrast, miR-181a inhibition via decoy vector suppression and Smad7 re-expression results in significant reversion of these phenotypes. Combined, our findings highlight an unappreciated role for miR-181a, Smad7, and the TGF-β signalling pathway in high-grade serous ovarian cancer.

1 April 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DDDipali Date
Dipali Date
RDRiku Das
Riku Das
GNGoutham Narla
Goutham Narla
DSDaniel I. Simon
Daniel I. Simon
MJMukesh K. Jain
Mukesh K. Jain
Ganapati H MahabeleshwarGanapati H Mahabeleshwar
Ganapati H Mahabeleshwar
Accumulating evidence supports the importance of macrophage plasticity in a broad spectrum of biological processes operative in health and disease. A major locus of control regulating macrophage polarization is at the transcriptional level, and several major pathways have been elucidated in recent years. In this study, we identify the Kruppel-like transcription factor 6 (KLF6) as a molecular toggle controlling macrophage speciation. KLF6 expression was robustly induced by pro-inflammatory M1 stimuli (e.g. LPS and IFN-γ) and strongly suppressed by M2 stimuli (e.g. IL4 and IL-13) in human and murine macrophages. Gain- and loss-of-function studies suggest that KLF6 is required for optimal LPS-induced pro-inflammatory gene expression, acting cooperatively with NF-κB. Furthermore, KLF6 inhibits anti-inflammatory gene expression by negatively regulating peroxisome proliferator-activated receptor γ expression in macrophages. Collectively, these observations identify KLF6 as a novel transcriptional regulator of macrophage polarization.

15 February 2005 in Cancer Research
Verified
Journal Article
Closed access
PDF file
GNGoutham Narla
Goutham Narla
ADAnalisa DiFeo
Analisa DiFeo
HRHelen L. Reeves
Helen L. Reeves
DSDaniel J. Schaid
Daniel J. Schaid
JHJennifer Hirshfeld
Jennifer Hirshfeld
JMJohn A. Martignetti
John A. Martignetti
Prostate cancer is a leading and increasingly prevalent cause of cancer death in men. Whereas family history of disease is one of the strongest prostate cancer risk factors and suggests a hereditary component, the predisposing genetic factors remain unknown. We first showed that KLF6 is a tumor suppressor somatically inactivated in prostate cancer and since then, its functional loss has been further established in prostate cancer cell lines and other human cancers. Wild-type KLF6, but not patient-derived mutants, suppresses cell growth through p53-independent transactivation of p21. Here we show that a germline KLF6 single nucleotide polymorphism, confirmed in a tri-institutional study of 3,411 men, is significantly associated with an increased relative risk of prostate cancer in men, regardless of family history of disease. This prostate cancer–associated allele generates a novel functional SRp40 DNA binding site and increases transcription of three alternatively spliced KLF6 isoforms. The KLF6 variant proteins KLF6-SV1 and KLF6-SV2 are mislocalized to the cytoplasm, antagonize wtKLF6 function, leading to decreased p21 expression and increased cell growth, and are up-regulated in tumor versus normal prostatic tissue. Thus, these results are the first to identify a novel mechanism of self-encoded tumor suppressor gene inactivation and link a relatively common single nucleotide polymorphism to both regulation of alternative splicing and an increased risk in a major human cancer.

20 April 2020 in Cell
Verified
Journal Article
Closed access
DLDaniel Leonard
Daniel Leonard
WHWei Huang
Wei Huang
SISudeh Izadmehr
Sudeh Izadmehr
COCaitlin M. O’connor
Caitlin M. O’connor
DWDanica D. Wiredja
Danica D. Wiredja
GNGoutham Narla
Goutham Narla